Please try another search
Biocartis Group NV, a molecular diagnostics company, provides diagnostic solutions enhancing clinical practice for the benefit of patients, clinicians, payers, and healthcare industry with a focus on oncology. Its proprietary molecular diagnostics Idylla platform is a real-time polymerase chain reaction system that offers molecular information that allows treatment selection and treatment progress monitoring. The company offers Idylla BRAF, KRAS, MSI, EGFR, and NRAS-BRAF mutation tests; and Idylla SARS-CoV-2/Flu/RSV panels and SARS-CoV-2 tests, as well as SeptiCyte RAPID, a rapid host-response test. It also provides research products, including MSI, KRAS, BRAF, ctEGFR, NRAS-BRAF-EGFR S492R, ctKRAS, EGFR, GeneFusion, ctBRAF, and ctNRAS-BRAF-EGFR S492R mutation assays. The company has a collaboration agreement with Amgen to evaluate Idylla RAS testing as a tool for rapid decentralized testing and/or to accelerate access to RAS biomarker information using Idylla platform and RAS tests; and Bristol-Myers Squibb Company for the registration of diagnostic and use of the Idylla MSI test in connection with immuno-oncology therapies. It also has a license, development, and commercialization agreement with GeneproDx for the development of ThyroidPrint novel genomic test on the Idylla platform; and collaboration with APIS Assay Technologies Ltd. to develop and commercialize breast cancer subtyping test on the Idylla platform. The company was founded in 2007 and is headquartered in Mechelen, Belgium.
Name | Age | Since | Title |
---|---|---|---|
Michael F. Press | - | - | Member of Scientific Advisory Board |
Ann-Christine Sundell | 59 | 2018 | Non Executive Independent Director |
Jean-Louis Vincent | - | - | Member of Scientific Advisory Board |
Eric Van Cutsem | - | - | Member of Scientific Advisory Board |
Alberto Bardelli | - | - | Member of Scientific Advisory Board |
Pasi Antero Janne | - | - | Member of Scientific Advisory Board |
Bert Niesters | 65 | - | Member of Scientific Advisory Board |
Luc Gijsens | 69 | 2018 | Non-Executive Independent Director |
Josep Tabernero | - | - | Member of Scientific Advisory Board |
Bryan M. Dechairo | 50 | 2023 | Non-Executive Independent Director |
Christine D. Kuslich | 55 | 2020 | Non Executive Independent Director |
Herman Verrelst | 49 | 2017 | Independent Chairman of the Board |
Geert Maertens | - | - | Chairman of Scientific Advisory Board & Chief Scientific Officer |
Christian Reinaudo | 69 | 2018 | Independent Director |
Anthony Sireci | - | 2023 | Member of Medical Advisory Board |
Maria Arcila | - | 2023 | Member of Medical Advisory Board |
Bradley Carl Meyer | - | 2024 | Independent Director |
David W. Young | - | 2024 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review